amikacin has been researched along with Necrotizing Pyelonephritis in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (41.67) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antonopoulou, A; Baziaka, F; Giamarellos-Bourboulis, EJ; Giamarellou, H; Kousoulas, V; Koutoukas, P; Panagou, C; Perrea, D; Sabracos, L | 1 |
| Adamis, T; Baziaka, F; Giamarellos-Bourboulis, E; Giamarellou, H; Karayannacos, P; Koutoukas, P; Plachouras, D; Raftogiannis, M; Sabracos, L; Tsaganos, T | 1 |
| Adamis, T; Antonopoulou, A; Giamarellos-Bourboulis, EJ; Giamarellou, H; Koutoukas, P; Panagou, C; Raftogiannis, M; Tsaganos, T; Tziortzioti, V | 1 |
| Bartsokas, C; Delis, D; Kafetzis, DA; Maltezou, HC; Mavrikou, M; Paraskakis, I; Siafas, C | 1 |
| Calleja, J; Flores, G; Magaña, F; Nellen, H | 1 |
| Aboul-Enein, M; Sherif, M; Soliman, O | 1 |
| Höffler, D | 1 |
| Gayer, J | 1 |
| Eubanks, N; Gilbert, DN; Jackson, J | 1 |
| Hirose, T; Kumamoto, Y; Tanaka, N; Yokoo, A | 1 |
| Goto, T; Kawahara, K; Kawahara, M; Mahinose, S; Mizuma, Y; Ohi, Y; Sakamoto, N | 1 |
| Du, JZ; Jiang, YF; Liu, YH; Luo, MY; Qiu, ZD; Sheng, JQ; Wang, QN | 1 |
1 review(s) available for amikacin and Necrotizing Pyelonephritis
| Article | Year |
|---|---|
Acute bilateral emphysematous pyelonephritis successfully managed by medical therapy alone: a case report and review of the literature.
Topics: Adult; Amikacin; Cardiotonic Agents; Ceftriaxone; Diabetes Mellitus, Type 2; Dopamine; Emphysema; Female; Fluid Therapy; Humans; Hypoglycemic Agents; Insulin; Pyelonephritis; Radiography; Treatment Outcome | 2002 |
4 trial(s) available for amikacin and Necrotizing Pyelonephritis
| Article | Year |
|---|---|
Isepamicin versus amikacin for the treatment of acute pyelonephritis in children.
Topics: Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Escherichia coli; Escherichia coli Infections; Female; Gentamicins; Humans; Infant; Infant, Newborn; Male; Pyelonephritis; Treatment Outcome; Urine | 2000 |
Amikacin in the treatment of pyelonephritis.
Topics: Aged; Amikacin; Clinical Trials as Topic; Double-Blind Method; Female; Gentamicins; Glomerular Filtration Rate; Humans; Kanamycin; Kinetics; Male; Pyelonephritis | 1979 |
Comparison of amikacin and gentamicin in the treatment of urinary tract infections.
Topics: Adolescent; Adult; Aged; Amikacin; Female; Gentamicins; Humans; Kanamycin; Male; Middle Aged; Prospective Studies; Pyelonephritis; Urinary Tract Infections | 1977 |
Laboratory and clinical studies on amikacin.
Topics: Amikacin; Bacterial Infections; Clinical Trials as Topic; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Kanamycin; Pyelonephritis; Sepsis; Staphylococcus aureus | 1985 |
7 other study(ies) available for amikacin and Necrotizing Pyelonephritis
| Article | Year |
|---|---|
Clarithromycin co-administered with amikacin attenuates systemic inflammation in experimental sepsis with Escherichia coli.
Topics: Acute Disease; Amikacin; Animals; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Humans; Inflammation; Lipopolysaccharides; Malondialdehyde; Pyelonephritis; Rabbits; Sepsis; Treatment Outcome; Tumor Necrosis Factor-alpha | 2005 |
Clarithromycin: immunomodulatory therapy of experimental sepsis and acute pyelonephritis by Escherichia coli.
Topics: Acute Disease; Amikacin; Animals; Anti-Bacterial Agents; Caspase 3; Caspases; Clarithromycin; Colony Count, Microbial; Escherichia coli; Escherichia coli Infections; Immunologic Factors; Male; Malondialdehyde; Pulmonary Edema; Pyelonephritis; Rabbits; Sepsis; Tumor Necrosis Factor-alpha | 2005 |
Clarithromycin is an effective immunomodulator when administered late in experimental pyelonephritis by multidrug-resistant Pseudomonas aeruginosa.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Immunologic Factors; Kidney; Lipopolysaccharides; Liver; Lung; Male; Malondialdehyde; Monocytes; Pseudomonas aeruginosa; Pseudomonas Infections; Pyelonephritis; Rabbits; Spleen; Tumor Necrosis Factor-alpha | 2006 |
Amikacin in the treatment of genito-urinary tract infections in cancer patients.
Topics: Adult; Aged; Amikacin; Cystitis; Escherichia coli Infections; Female; Humans; Kanamycin; Male; Middle Aged; Pseudomonas Infections; Pyelonephritis; Urinary Bladder Neoplasms | 1978 |
[Therapy of pyelonephritis].
Topics: Amikacin; Amoxicillin; Ampicillin; Carbenicillin; Cephalosporins; Chloramphenicol; Gentamicins; Humans; Nalidixic Acid; Penicillin Resistance; Pivampicillin; Pyelonephritis; Sulfonamides; Tetracyclines; Tobramycin; Trimethoprim | 1977 |
[Study of the effect of combination therapy of human granulocyte-colony stimulating factor (G-CSF) and amikacin on experimental pyelonephritis induced by Pseudomonas aeruginosa in neutropenic mice].
Topics: Amikacin; Animals; Combined Modality Therapy; Female; Granulocyte Colony-Stimulating Factor; Mice; Mice, Inbred Strains; Neutropenia; Pseudomonas Infections; Pyelonephritis | 1990 |
Experimental bacterial prostatitis in rats.
Topics: Amikacin; Animals; Enterococcus faecalis; Escherichia coli Infections; Male; Prostatitis; Pyelonephritis; Rats; Rats, Inbred Strains; Streptococcal Infections; Urethra | 1991 |